Specific responses in rat small intestinal epithelial mRNA expression and protein levels during chemotherapeutic...

Area of Science:

• Gastroenterology
• Molecular Biology
• Pharmacology

Background:

• The small intestinal epithelium rapidly divides and is sensitive to chemotherapy.
• Methotrexate (MTX) is a cytostatic drug commonly used in cancer treatment.
• Understanding MTX-induced intestinal damage is crucial for managing side effects.

Purpose of the Study:

• To investigate the regulation of epithelial gene expression in rat jejunum during MTX-induced damage and regeneration.
• To analyze correlations in temporal expression patterns between differentiation markers.
• To assess changes at both mRNA and protein levels.

Main Methods:

• Localization and quantification of ten differentiation markers in rat jejunum tissue sections.
• Measurement of mRNA and protein levels relative to control groups.
• Analysis of correlations between temporal expression patterns of various markers.

Main Results:

• MTX treatment significantly decreased mRNA expression of enterocyte and goblet cell markers, with specific correlations observed (e.g., sucrase-isomaltase and CPS).
• Fatty acid transporters (I-FABP, L-FABP) and glucose transporters (GLUT5) showed decreased mRNA expression.
• Lysozyme mRNA in Paneth cells increased, while MUC2 and TFF3 mRNA expression changes were independent of other markers. Protein levels generally agreed with mRNA, with notable increases in Muc2 and TFF3 during damage.
• During regeneration, all marker expressions returned to control levels.

Conclusions:

• Enhanced expression of cytoprotective molecules (Muc2, TFF3, lysozyme) during MTX damage likely serves to protect the intestinal epithelium.
• Decreased expression of enterocyte-specific markers reflects reduced enterocyte function, with fatty acid transporters being least affected.
• These findings highlight the complex molecular responses of the small intestine to chemotherapy and the potential for targeted protective strategies.